Telehealth provider Hims & Hers Health (NYSE:HIMS) outperformed Wall Street expectations in Q2 CY2026, delivering a 38.2% year-over-year revenue surge to $753.2 million. Despite this strong top-line performance and a robust third-quarter revenue guidance of $890 million—exceeding analyst projections by 12.4%—the company’s stock fell 5.3% to $30.21 following the announcement, driven by a GAAP loss of $0.37 per share that missed market consensus.
Evaluating Long-Term Growth Trajectory
Originally established to address stigmatized health concerns such as hair loss and sexual wellness, Hims & Hers has evolved into a comprehensive consumer-focused telehealth platform. The company’s long-term quality is anchored by an impressive 67.5% annualized revenue growth rate over the past five years, significantly outperforming the broader healthcare sector.
While the company’s two-year annualized growth rate of 55.4% shows a slight deceleration from its five-year trend, the results underscore sustained consumer demand. This momentum is further validated by the company’s customer base, which reached 2.89 million in the most recent quarter. With a 25.1% average year-over-year growth in subscribers over the last two years—a figure lower than total revenue growth—it is clear that the average customer is increasing their annual spend on the platform’s products and services.
Revenue Outlook and Market Expectations
Hims & Hers delivered a strong quarter, with revenue beating Wall Street estimates by 7.8%. Management remains optimistic, projecting a 48.6% year-over-year sales increase for the coming quarter. Although sell-side analysts anticipate a moderation in growth to 25.7% over the next 12 months, the outlook remains positive, suggesting that the company’s service offerings continue to find a strong market fit.
Profitability and Operating Margins
Operating margin remains a critical metric for assessing the company’s path to profitability. Historically, Hims & Hers has faced challenges with high expenses, posting an average operating margin of negative 2.3% over the last five years. While the company saw a 17.1 percentage point expansion in margins over that five-year period due to operating leverage, recent performance shows a 7.1 percentage point contraction on a two-year basis. For the current quarter, the operating margin stood at negative 12.9%.
Earnings Per Share and Future Outlook
While the company is yet to achieve full-year profitability, it has managed to improve its EPS by 2% annually over the last five years. However, the Q2 EPS of negative $0.37 represented a decline from the $0.17 reported in the same period last year, missing analyst expectations. As the company navigates these headwinds, the focus remains on reaching a definitive inflection point toward sustainable profitability.
Ultimately, while Hims & Hers exceeded revenue expectations and provided encouraging forward guidance, the market reaction reflects investor caution regarding the bottom-line performance. The company continues to demonstrate high-quality revenue growth, yet the coming quarters will be pivotal in determining whether it can successfully translate that scale into consistent earnings.